Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imagin
published in: PLOS One
date of publication: 2014-11-24
language: English
main subject: chemoradiotherapy, temozolomide, glioblastoma
Cites articles 42
- 2009-05-01
Date
Title
Article - wd:Q30871297